ESPI Current Report, No. 16/2023, Publication of the development strategy of the Company MYCODERN S.A. (PLMDNPL00013)

05-10-2023 20:15:14 | Current | ESPI | 16/2023

Legal basis
Article 17 (1) MAR – confidential information.
Contents of the report:

The Management Board of Mycodern S.A. with its seat in Gdańsk _”the Company”_ informs that today it has prepared and adopted a strategy for the development of the Mycodern Group in 2023 – 2025.
The strategy is based on the following directions:
1. expansion of the Group’s product offering into new markets, including those in Asia and the United States,
2. increasing brand recognition in Poland and Europe,
3. expanding the Group’s product offering with new products,
4. acquiring a strategic partner to help acquire new, broad product distribution opportunities and strengthen the brand in European markets,
5. recapitalization of Group companies.
A detailed outline of the Group’s strategy is attached to this report.


Strategia i prezentacja Grupy Kapitałowej Mycodern.pdf

  • Bartosz Groth- President of the Management Board

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top